protective effect of zinc supplementation in long standing obstructive lung disease
Phase 4
Completed
- Conditions
- Health Condition 1: null- chronic obstructive pulmonary disease
- Registration Number
- CTRI/2017/11/010437
- Lead Sponsor
- Dr VASANTH S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
1)18 years â?? 70 years of age both sex
2) Clinically diagnosed stable cases of chronic obstructive pulmonary disease (FEV1 / FVC <0.7).
3) GOLD 1 and GOLD 2 patients will be included
Exclusion Criteria
1) less than 18 years,more than 70 years
2) Patients with other pulmonary diseases ,COPD patients in GOLD3 and GOLD4
3) Chronic obstructive pulmonary disease with acute exacerbations with upper respiratory and lower respiratory tract infection
4) COPD patients with previous history of exacerbation more than 2 per year will be excluded
5) Patients with Cardiac disease, hepatic disease, renal disease ,diabetes and hypertension
6) Patients on any other antioxidant intake
7) pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pulmonary function test FEV1/FVC ratio, FEV1,serum superoxide dismutase .Timepoint: 12 weeks
- Secondary Outcome Measures
Name Time Method pulmonary function test FEV1/FVC ratio, FEV1Timepoint: 6 months